On October 8, 2026, several stocks including AngioDynamics, Apimeds Pharmaceuticals US, and Arqit Quantum experienced steep declines of over 18%, despite some positive financial reports. Leveraged ETFs CRWG and IRE also dropped 15.5%, highlighting the volatility and risk of daily-reset leveraged products. No clear catalysts were identified for most of the losses, underscoring market uncertainty. Investors should be cautious with leveraged ETFs due to their amplified risk during volatile periods.
Arqit Quantum Inc (ARQQ) continues to show significant weakness, trading at USD 18.79 with a 1-day decline of 16.67% on Pluang. The stock's market cap stands at $393.56 million, and it remains closer to its 52-week low of $11.78 than its high. These figures are current as of October 9, 2026, 04:11 WIB.
